Prescription Justice recently joined with nine other health, social justice and consumer advocacy organizations to launch a petition to demand Congress act to bring relief to the millions of Americans who can't afford the prescription drugs they need.
The online petition largely echoes the Prescription Justice policy platform which prioritizes ending the ban on Medicare negotiating drug prices, making pay-for-delay deals illegal, and permitting wider access to lower-cost, imported medication through legislative, regulatory, and policy reforms. (more…)
President Trump reinvigorated the drug price policy debate by recently stating that prescription drug prices "are out of control" and, for a second time, that drug companies are "getting away with murder". He's expected to soon announce a bi-partisan drug price task force to examine prescription drug costs. The president's renewed focus on lowering drug costs is a relief from the misaligned priority of healthcare reform, which seems to have overshadowed Americans most pressing healthcare concern: soaring drug costs.
In his most recent remarks, President Trump focused on the fact that prescription drugs are much cheaper in other countries. In fact, it's common for brand-name prescription drug prices to be as much as 90 percent lower in pharmacies outside the U.S., which is why millions of Americans, despite federal restrictions, have had to import medication from Canada and elsewhere. Unfortunately, the law and misleading public information campaigns sponsored by drug companies scare Americans away from more affordable medication. (more…)
The Prescription Justice coalition letter from last month, signed by a growing number of consumer, health and social justice organizations, supports S. 469/H.R. 1245, The Affordable and Safe Prescription Drug Importation Act of 2017, introduced by Senator Bernie Sanders, I-VT and Representative Elijah Cummings, D-MD. If enacted, this bill would allow individuals, pharmacies and wholesalers to import FDA-approved medications from Canada, and then, after two years, from other countries with equally rigorous systems for regulating the safety and efficacy of pharmaceuticals.
Prescription Justice also supports S. 64 /H.R. 1480, The Safe and Affordable Drugs from Canada Act of 2017, introduced by Senator John McCain, R-AZ and Representative Chellie Pingree, D-ME. This bill wouldallow for the personal importation of safe and affordable drugs from approved pharmacies in Canada. Prescription medications imported under this bill would be the same dosage, form, and potency as drugs in the U.S., but at a significant savings to Americans.
The Brussels Principles underscore the importance of the international online marketplace as a lifeline of affordable medication for the millions of people forced to go without necessary treatment due to drug cost and availability.
On March 31st, 2017, Prescription Justice organized a panel for the RightsCon 2017 conference in Brussels, which addressed protecting online access to safe and affordable medication. The organizers of RightsCon just published their outcomes document in which Prescription Justice’s effort to bring together both medicines access and Internet freedom advocates was recognized.
At that conference, the participants discussed a set of draft principles pertaining to medication sales over the Internet and prescription drug importation. The prevailing position among the panelists was that initiatives funded by the pharmaceutical industry that affect access to medicines on the Internet were detrimental to the cause of prescription drug affordability.